Skip to content
Trending storyDeveloping

Evolutionary constraint metrics across 462 mammals sharpen human disease gene prioritization

1 report1 sourceupdated 20 hours ago

Start here

Synthesis

Researchers have built two metrics of evolutionary constraint, GISMO and GISMO-mis, using gene loss and missense variation mapped across 462 mammalian species. Together the measures offer complementary assessments of gene essentiality: when a gene is rarely lost or rarely accumulates missense changes across the mammalian tree, it is more likely to be essential. Applied to human data, the metrics improve prioritization of candidate human disease genes, giving clinicians and researchers a way to rank genes underlying both rare and common conditions. The work was published in Nature Genetics on 20 October 2026. Open questions include how the metrics perform for genes with weak evolutionary signal and how they will be integrated into existing variant-interpretation pipelines in clinical genetics.

Written by a model from the reports · updated 4 hours ago

Coverage timeline

Follow the coverage to see the different angles.

Oct 20
  1. NaturePick
    The landscape of gene loss and missense variation across the mammalian tree informs on gene essentiality

    The authors developed two metrics of evolutionary constraint, GISMO and GISMO-mis, across 462 mammalian species to complement assessments of gene essentiality. The two metrics provide complementary measures of gene essentiality and improve prioritization of human disease genes. The study was published in Nature Genetics, DOI 10.1038/s41588-026-02783-9, at https://www.nature.com/articles/s41588-026-02783-9.

Coverage and heat for this story

Reports so far 1·Heat now 6·Peak heat 10 (Oct 20 08:00)·Reports, 24h +1

Cumulative reports
00.51
Heat index (decays)
0510Oct20Oct20Oct20Oct21

Two panels, same clock (pointer stays in sync): top is cumulative editorial reports — only rises; last point = All reports; slope = new reports that hour. Bottom is Live-board heatIndex — 7-day participants with a 24-hour half-life, so it can fall when talk cools.

CBACBA Frontier Insights (CFI)Chinese Biopharmaceutical Association (CBA)www.cba-usa.org